文献速递外周动脉疾病

编辑精选——美国因跛行行膝下外周血管介入频繁且与不良长期结局相关

Editor's Choice - Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes.
PubMed 文献 · Eur J Vasc Endovasc Surg · 2024-06-19

基于2017至2019年美国联邦医疗保险按服务收费索赔数据,回顾性分析36 147例因跛行行膝下外周血管介入(PVI)的患者。膝下PVI较孤立股腘PVI与更高的3年转为慢性肢体威胁性缺血、重复PVI和重大截肢累积发生率及校正风险相关。

要点

  • 因跛行行膝下PVI占32.6%,其中38.6%为孤立膝下PVI。
  • 膝下PVI组3年转为慢性肢体威胁性缺血累积发生率为26.0%。
  • 膝下PVI组3年重大截肢累积发生率为2.2%。

核心结论

  • 因跛行行膝下PVI较孤立股腘PVI与更差的长期结局相关。

研究设计与样本

  • 回顾性分析2017至2019年美国联邦医疗保险按服务收费索赔全国行政数据库,纳入36 147例因跛行行首次腹股沟下PVI的患者。

主要发现

  • 膝下PVI组3年转为慢性肢体威胁性缺血累积发生率为26.0%(95%CI 24.9-27.2%),孤立股腘PVI组为19.9%(95%CI 19.1-20.7%)。
  • 膝下PVI组3年重复PVI累积发生率为56.0%(95%CI 54.8-57.3%),孤立股腘PVI组为45.7%(95%CI 44.9-46.6%)。
  • 膝下PVI组3年重大截肢累积发生率为2.2%(95%CI 1.8-2.6%),孤立股腘PVI组为1.3%(95%CI 1.1-1.5%)。
  • 校正患者和医生层面特征后,膝下PVI组转为慢性肢体威胁性缺血的aHR为1.31(95%CI 1.23-1.39),重复PVI的aHR为1.12(95%CI 1.05-1.20),重大截肢的aHR为1.72(95%CI 1.42-2.07)。
  • 首次干预中治疗的膝下血管数量增加与结局越来越差相关(趋势P<.001)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Infrapopliteal peripheral vascular interventions (PVIs) for claudication are still performed in the USA. This study aimed to evaluate whether infrapopliteal PVI is associated with worse long term outcomes than isolated femoropopliteal PVI for treatment of claudication. METHODS: A retrospective analysis of fee for service claims in a national administrative database was conducted using 100% of the Medicare fee for service claims between 2017 and 2019 to capture all Medicare beneficiaries who underwent an index infra-inguinal PVI for claudication. Hierarchical Cox proportional hazards models were performed to assess the association of infrapopliteal PVI with conversion to chronic limb threatening ischaemia (CLTI), repeat PVI, and major amputation. RESULTS: In total, 36 147 patients (41.1% female; 89.7% age ≥ 65 years; 79.0% non-Hispanic White ethnicity) underwent an index PVI for claudication, of whom 32.6% (n = 11 790) received an infrapopliteal PVI. Of these, 61.4% (n = 7 245) received a concomitant femoropopliteal PVI and 38.6% (n = 4 545) received an isolated infrapopliteal PVI. The median follow up time was 3.5 years (interquartile range 2.7, 4.3). Patients receiving infrapopliteal PVI had a higher three year cumulative incidence of conversion to CLTI (26.0%; 95% confidence interval [CI] 24.9 - 27.2% vs. 19.9%; 95% CI 19.1 - 20.7%), repeat PVI (56.0%; 95% CI 54.8 - 57.3% vs. 45.7%; 95% CI 44.9 - 46.6%), and major amputation (2.2%; 95% CI 1.8 - 2.6% vs. 1.3%; 95% CI 1.1 - 1.5%) compared with patients receiving isolated femoropopliteal PVI. After adjusting for patient and physician level characteristics, the risk of conversion to CLTI (adjusted hazard ratio [aHR] 1.31, 95% CI 1.23 - 1.39), repeat PVI (aHR 1.12, 95% CI 1.05 - 1.20), and major amputation (aHR 1.72, 95% CI 1.42 - 2.07) remained significantly higher for patients receiving infrapopliteal PVI. An increasing number of infrapopliteal vessels treated during the index intervention was associated with increasingly poor outcomes (p < .001 for trend). CONCLUSION: Infrapopliteal PVI for claudication is associated with worse long term outcomes relative to isolated femoropopliteal PVI.

来源:Eur J Vasc Endovasc Surg,查看原文。版权归原作者所有。

引用

  1. Bose S, Dun C, Solomon AJ, et al. Editor's Choice - Infrapopliteal Peripheral Vascular Interventions for Claudication are Performed Frequently in the USA and Are Associated with Poor Long Term Outcomes. Eur J Vasc Endovasc Surg. 2024. PMID: 38906366. doi:10.1016/j.ejvs.2024.06.017

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。